Impaired SERCA2a phosphorylation causes diabetic cardiomyopathy through impinging on cardiac contractility and precursor protein processing

Abstract

Diabetic cardiomyopathy (DCM) is currently a progressive and nonstoppable complication in type 2 diabetic patients. Metabolic insults and insulin resistance are involved in its pathogenesis; however, the underlying mechanisms are still not clearly understood. Here we show that calcium dysregulation can be both a cause and a consequence of cardiac insulin resistance that leads to DCM. A western diet induces the development of DCM through at least three phases in mice, among which an early phase depends on impaired Thr⁴⁸⁴-phosphorylation of sarcoplasmic/endoplasmic reticulum calcium ATPase 2a (SERCA2a) elicited by insulin resistance. Mutation of SERCA2a-Thr⁴⁸⁴ to a nonphosphorylatable alanine delays calcium re-uptake into the sarcoplasmic reticulum in the cardiomyocytes and decreases cardiac function at the baseline. Importantly, this mutation blunts the early phase of DCM, but has no effect on disease progression in the following phases. Interestingly, impairment of sarcoplasmic reticulum calcium re-uptake caused by the SERCA2a-Thr⁴⁸⁴ mutation inhibited processing of insulin receptor precursor through FURIN convertase, resulting in cardiac insulin resistance. Collectively, these data reveal a bidirectional relationship between insulin resistance and impairment of calcium homeostasis, which may underlie the early pathogenesis of DCM. Our findings have therapeutic implications for early intervention of DCM.

Keywords

SERCA / SPEG / phosphorylation / calcium / insulin / diabetic cardiomyopathy

References

[1] Jia G, DeMarco VG, Sowers JR. Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy. Nat Rev Endocrinol 2016; 12: 144- 53.

[2] Bugger H, Abel ED. Molecular mechanisms of diabetic cardiomyopathy. Diabetologia 2014; 57: 660- 71.

[3] Ritchie RH, Abel ED. Basic mechanisms of diabetic heart disease. Circ Res 2020; 126: 1501- 25.

[4] Shah MS, Brownlee M. Molecular and cellular mechanisms of cardiovascular disorders in diabetes. Circ Res 2016; 118: 1808- 29.

[5] Dillmann WH. Diabetic cardiomyopathy. Circ Res 2019; 124: 1160- 2.

[6] Draznin B. Cytosolic calcium and insulin resistance. Am J Kidney Dis 1993; 21: 32- 8.

[7] Braunwald E. The war against heart failure: the Lancet lecture. Lancet 2015; 385: 812- 24.

[8] Gorski PA, Ceholski DK, Hajjar RJ. Altered myocardial calcium cycling and energetics in heart failure--a rational approach for disease treatment. Cell Metab 2015; 21: 183- 94.

[9] Meyer M, Schillinger W, Pieske B et al. Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy. Circulation 1995; 92: 778- 84.

[10] Quan C, Li M, Du Q et al. SPEG controls calcium reuptake into the sarcoplasmic reticulum through regulating SERCA2a by its second kinase-domain. Circ Res 2019; 124: 712- 26.

[11] Quan C, Du Q, Li M et al. A PKB-SPEG signaling nexus links insulin resistance with diabetic cardiomyopathy by regulating calcium homeostasis. Nat Commun, 2020; 11: 2186.

[12] Hsieh CM, Fukumoto S, Layne MD et al. Striated muscle preferentially expressed genes alpha and beta are two serine/threonine protein kinases derived from the same gene as the aortic preferentially expressed gene-1. J Biol Chem 2000; 275: 36966- 73.

[13] Verboven M, Deluyker D, Ferferieva V et al. Western diet given to healthy rats mimics the human phenotype of diabetic cardiomyopathy. J Nutr Biochem 2018; 61: 140- 6.

[14] Periasamy M, Reed TD, Liu LH et al. Impaired cardiac performance in heterozygous mice with a null mutation in the sarco(endo)plasmic reticulum Ca²⁺-ATPase isoform 2 (SERCA2) gene. J Biol Chem 1999; 274: 2556- 62.

[15] Publicover SJ, Duncan CJ, Smith JL. The use of A23187 to demonstrate the role of intracellular calcium in causing ultrastructural damage in mammalian muscle. J Neuropathol Exp Neurol 1978; 37: 554- 7.

[16] Bravo DA, Gleason JB, Sanchez RI et al. Accurate and efficient cleavage of the human insulin proreceptor by the human proprotein-processing protease furin. Characterization and kinetic parameters using the purified, secreted soluble protease expressed by a recombinant baculovirus. J Biol Chem 1994; 269: 25830- 7.

[17] Molloy SS, Bresnahan PA, Leppla SH et al. Human furin is a calcium-dependent serine endoprotease that recognizes the sequence Arg-X-X-Arg and efficiently cleaves anthrax toxin protective antigen. J Biol Chem 1992; 267: 16396- 402.

[18] Lehmann M, Andre F, Bellan C et al. Deficient processing and activity of type I insulin-like growth factor receptor in the furin-deficient LoVo-C5 cells. Endocrinology 1998; 139: 3763- 71.

[19] Atisha D, Bhalla MA, Morrison LK et al. A prospective study in search of an optimal B-natriuretic peptide level to screen patients for cardiac dysfunction. Am Heart J 2004; 148: 518- 23.

[20] Brown MS, Goldstein JL. Selective versus total insulin resistance: a pathogenic paradox. Cell Metab 2008; 7: 95- 6.

[21] Konner AC, Bruning JC. Selective insulin and leptin resistance in metabolic disorders. Cell Metab 2012; 16: 144- 52.

[22] Han J, Li E, Chen L et al. The CREB coactivator CRTC2 controls hepatic lipid metabolism by regulating SREBP1. Nature 2015; 524: 243- 6.

[23] Kubota T, Kubota N, Kadowaki T. Imbalanced insulin actions in obesity and type 2 diabetes: key mouse models of insulin signaling pathway. Cell Metab 2017; 25: 797- 810.

[24] Leduc R, Molloy SS, Thorne BA et al. Activation of human furin precursor processing endoprotease occurs by an intramolecular autoproteolytic cleavage. J Biol Chem 1992; 267: 14304- 8.

[25] Robertson BJ, Moehring JM, Moehring TJ. Defective processing of the insulin receptor in an endoprotease-deficient Chinese hamster cell strain is corrected by expression of mouse furin. J Biol Chem 1993; 268: 24274- 7.

[26] Kho C, Lee A, Jeong D et al. SUMO1-dependent modulation of SERCA2a in heart failure. Nature 2011; 477: 601- 5.

[27] Tilemann L, Lee A, Ishikawa K et al. SUMO-1 gene transfer improves cardiac function in a large-animal model of heart failure. Sci Transl Med 2013; 5: 211ra159.

[28] Kho C, Lee A, Jeong D et al. Small-molecule activation of SERCA2a SUMOylation for the treatment of heart failure. Nat Commun 2015; 6: 7229.

[29] Quan C, Xie B, Wang HY et al. PKB-mediated Thr649 phosphorylation of AS160/TBC1D4 regulates the R-wave amplitude in the heart. PLoS One 4491 2015; 10: e0124491.

[30] Xu X, Yang D, Ding JH et al. ASF/SF2-regulated CaMKIIdelta alternative splicing temporally reprograms excitation-contraction coupling in cardiac muscle. Cell 2005; 120: 59- 72.

[31] Dittami GM, Rajguru SM, Lasher RA et al. Intracellular calcium transients evoked by pulsed infrared radiation in neonatal cardiomyocytes. J Physiol 2011; 589: 1295- 306.

RIGHTS & PERMISSIONS

2022 The Author(s) 2022. Published by Oxford University Press on behalf of Higher Education Press.